Skip to content

ASLN — Aslan Pharmaceuticals Lt Adr Institutional Holders · Q2 2026

Who owns Aslan Pharmaceuticals Lt Adr (ASLN)? 1 institutions reported holding $17 in SEC 13F filings for Q2 2026 (period ended 2026-06-30). Largest holders: Rhumbline Advisers ($17).

RankInstitutionValueSharesChange
1RHUMBLINE ADVISERS$1729Hold

Source: SEC Form 13F filings · as of 2026-06-30